<DOC>
	<DOC>NCT02729155</DOC>
	<brief_summary>This trial is a 2 x 2 factorial design, double-blinded, randomized controlled trial to evaluate efficacy and safety of remote ischemic preconditioning and postconditioning for prevention of contrast-induced acute kidney injury in patient undergoing coronary angiography and angioplasty</brief_summary>
	<brief_title>Single-cycle Remote Ischemic Preconditioning and Postconditioning for Prevention of Contrast-Induced Nephropathy (SCRIP-CIN) Trial</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<criteria>The patient have indication for coronary angiography or angioplasty. Impaired renal function with reduced eGFR &lt; 60 ml/min/1.73 m2 by CKDEPI equation. Written informed consent. History of contrast allergy. The patient had endstage renal failure with the need for hemodialysis. The patient take medications that affect the kidneys function within 48 hours before study. The patient had acute kidney injury from any cause. The patient was received contrast media within 2 weeks before study. The patient had cardiac arrest or shock. The patient had peripheral arterial disease (PAD) Pregnancy Refused to study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Ischemic Preconditioning</keyword>
	<keyword>Postconditioning</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Angiography</keyword>
	<keyword>Contrast-Induced Nephropathy</keyword>
</DOC>